SMARCD1 and breast cancer: To test if Smarcd1 expression could modify cellular processes associated with breast cancer progression in vitro, we created 6DT1 cells with knockdown (KD) or overexpression (OE) of Smarcd1, as well as appropriate control lines shScr or empty vector (EV), respectively (Fig. 3a).